ResMed (RMD) Competitors

ResMed (NYSE:RMD) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability, community ranking, risk and media sentiment.

Do analysts prefer RMD or MDT?

ResMed currently has a consensus price target of $258.83, indicating a potential upside of 9.54%. Medtronic has a consensus price target of $96.14, indicating a potential upside of 15.23%. Given Medtronic's higher probable upside, analysts plainly believe Medtronic is more favorable than ResMed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ResMed	1 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.60
Medtronic	1 Sell rating(s)	8 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.44

Does the MarketBeat Community favor RMD or MDT?

Medtronic received 1152 more outperform votes than ResMed when rated by MarketBeat users. Likewise, 75.45% of users gave Medtronic an outperform vote while only 52.65% of users gave ResMed an outperform vote.

Company	Underperform	Outperform
ResMed	Outperform Votes 437 52.65%	Underperform Votes 393 47.35%
Medtronic	Outperform Votes 1589 75.45%	Underperform Votes 517 24.55%

Does the media prefer RMD or MDT?

In the previous week, Medtronic had 25 more articles in the media than ResMed. MarketBeat recorded 56 mentions for Medtronic and 31 mentions for ResMed. Medtronic's average media sentiment score of 1.00 beat ResMed's score of 0.99 indicating that Medtronic is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ResMed	22 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medtronic	37 Very Positive mention(s)	5 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility and risk, RMD or MDT?

ResMed has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500.

Do insiders & institutionals have more ownership in RMD or MDT?

55.0% of ResMed shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 0.7% of ResMed shares are owned by insiders. Comparatively, 0.2% of Medtronic shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Is RMD or MDT a better dividend stock?

ResMed pays an annual dividend of $2.12 per share and has a dividend yield of 0.9%. Medtronic pays an annual dividend of $2.80 per share and has a dividend yield of 3.4%. ResMed pays out 23.8% of its earnings in the form of a dividend. Medtronic pays out 85.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. ResMed has raised its dividend for 13 consecutive years and Medtronic has raised its dividend for 48 consecutive years. Medtronic is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Is RMD or MDT more profitable?

ResMed has a net margin of 25.34% compared to Medtronic's net margin of 12.83%. ResMed's return on equity of 26.17% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ResMed	25.34%	26.17%	18.60%
Medtronic	12.83%	14.07%	7.70%

Which has better valuation and earnings, RMD or MDT?

Medtronic has higher revenue and earnings than ResMed. Medtronic is trading at a lower price-to-earnings ratio than ResMed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ResMed	$5.02B	6.90	$1.02B	$8.91	26.52
Medtronic	$33.20B	3.22	$3.68B	$3.29	25.36

Summary

Medtronic beats ResMed on 11 of the 21 factors compared between the two stocks.